San Diego, CA (PRWEB) March 24, 2013
Resource4thePeople announced today that its attorneys are investigating claims from consumers who are alleging that they suffered liver damage or failure problems because of their use of Tylenol and other acetaminophen medications.
“We have been receiving an increasing number of inquiries from consumers about what legal options may be available to them in connection with alleged serious liver problems that they are attributing to the use of Tylenol products,” said Resource4thePeople.
“Therefore, we are informing consumers that our team of nationwide lawyers not only will be investigating such claims, they will also be offering free consultations to consumers who believe that they may have such a claim.”
Resource4thePeople is learning that many of the consumers who have made inquiries were unfamiliar with some of the possible side effects from Tylenol products that could cause liver damage or failure. These are now being detailed on the Tylenol official web site.*
Included in these details is the warning: “It is important to be aware of the ingredients I all medications that you may be taking. Acetaminophen (APAP) is a common component of many different over-the-counter and prescription medications. You should not take two or more products that contain acetaminophen at the same time. Taking more than the recommended dose (overdose) of acetaminophen may cause liver damage.”
Resource4thePeople also is informing consumers inquiring about Tylenol claims about a health update** issued by the Food and Drug Administration that warns about liver damage due to large doses of the medication, using it with other acetaminophen-based medications or with alcohol or other drugs.
The FDA cites the dangers of liver damage or failure, kidney failure or heart problems, seizures, and death.
“These are serious health issues that -- because of the huge popularity of these drugs -- are causing widespread concern among consumers,” said Resource4thePeople “Our attorneys are now actively investigating the concerns and claims that are being alleged in increasing numbers by consumers concerned about side effects.”
Resource4thePeople also is announcing that it will inform consumers who may have suffered liver damage as a result of the use of Tylenol and other acetaminophen medications about the results of an important court date involving lawsuits that have been filed so far over these claims.
The United States Judicial Panel on Multidistrict Litigation has agreed*** to hear a petition from plaintiffs who have filed Tylenol liver failure allegation lawsuits to consolidate those lawsuits before a single federal judge.
The hearing on the petition is scheduled to be heard this month at the United States Courthouse Annex, Courtroom 15B, 333 West Broadway, San Diego, Ca.
“This is an important milestone in the progress of a growing number of lawsuits claiming that the use of Tylenol and other acetaminophen-based pain-killers can put patients at significantly increased risk of suffering life-threatening liver damage,” said Resource4thePeople.
“Resouce4thePeople remains committed to providing updates about the progress of this litigation and is also providing free legal consultations to individuals who may have suffered liver damage from Tylenol use. We welcome their inquiries and will investigate the merits of such cases.”
The petition to the United States Judicial Panel on Multidistrict Litigation states that “Centralization and consolidation of the Tylenol is beneficial to both plaintiffs and defendants, and reduces duplicative discovery, avoids conflicting rulings from different judges.”
Attorneys for the plaintiffs requested that the 28 cases currently pending against McNeil PPC Inc., McNeil Consumer Healthcare and Johnson & Johnson be coordinated and consolidated at the federal courthouse in Philadelphia.
“All of the products liability cases referenced by the plaintiffs’ lawyers allege that McNeil marketed and sold its over-the-counter Tylenol products in a manner that concealed the margin of risk of liver toxicity and liver failure,” according to the filings for the petition.
If the federal judicial panel decides to consolidate the cases before a single judge that judge would oversee pre-trial evidence-gathering, legal motions and settlement talks in the litigation.
The same judge also would decide on whether to grant class-action status to the litigation based on judicial efficiency, common claims by plaintiffs and common defendants.
Resource4thePeople said that the consultations with Tylenol liver damage allegation attorneys can provide legal options to men, women and children who allegedly have suffered liver damage or failure due to their use of Tylenol and other products containing the ingredient acetaminophen.
Legal assistance also is available to those who may have lost a loved one and may be seeking information about the facts involved in a wrongful death.
Resource4thePeople also is alerting consumers to a 2011 Drug Safety Communication about pain-killers containing acetaminophen in which the FDA announced that Tylenol and other drug manufacturers were being asked to limit the strength of acetaminophen in prescription drug products out of concern about liver problems.****
Soon afterward, McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, was among the companies announcing that it was reducing the recommended maximum daily dose of its Tylenol products.
Resource4thePeople said that it is imperative that consumers familiarize themselves with the current dosage requirements established by the FDA, which has warned that against overusing the medication in this flu season.
Acetaminophen is contained in many of the most popular cold and flu remedies, aids for sleeping, relief mixtures for headaches as well as being an ingredient in prescribed pain-killers.
Consumer4thePeople is urging consumers to complete familiarize themselves with the warning labels on such medications because these dosage changes that have been made at the direction of the FDA.
Read the full story at http://www.prweb.com/releases/2013/3/prweb10559265.htm.
Copyright©2012 Vocus, Inc.
All rights reserved